| Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition TR Arkell, N Lintzeris, RC Kevin, JG Ramaekers, R Vandrey, C Irwin, ... Psychopharmacology 236, 2713-2724, 2019 | 197 | 2019 |
| Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review D McCartney, TR Arkell, C Irwin, IS McGregor Neuroscience & Biobehavioral Reviews 126, 175-193, 2021 | 160 | 2021 |
| Effect of cannabidiol and Δ9-tetrahydrocannabinol on driving performance: a randomized clinical trial TR Arkell, F Vinckenbosch, RC Kevin, EL Theunissen, IS McGregor, ... Jama 324 (21), 2177-2186, 2020 | 156 | 2020 |
| Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18) N Lintzeris, L Mills, A Suraev, M Bravo, T Arkell, JC Arnold, MJ Benson, ... Harm reduction journal 17, 1-12, 2020 | 111 | 2020 |
| The failings of per se limits to detect cannabis-induced driving impairment: Results from a simulated driving study TR Arkell, TR Spindle, RC Kevin, R Vandrey, IS McGregor Traffic injury prevention 22 (2), 102-107, 2021 | 60 | 2021 |
| Are blood and oral fluid Δ9-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis D McCartney, TR Arkell, C Irwin, RC Kevin, IS McGregor Neuroscience & Biobehavioral Reviews 134, 104433, 2022 | 48 | 2022 |
| Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point‐of‐collection testing devices TR Arkell, RC Kevin, J Stuart, N Lintzeris, PS Haber, JG Ramaekers, ... Drug testing and analysis 11 (10), 1486-1497, 2019 | 48 | 2019 |
| Driving-related behaviours, attitudes and perceptions among Australian medical cannabis users: results from the CAMS 18-19 survey TR Arkell, N Lintzeris, L Mills, A Suraev, JC Arnold, IS McGregor Accident Analysis & Prevention 148, 105784, 2020 | 45 | 2020 |
| Medical cannabis and driving TR Arkell, D McCartney, IS McGregor Australian journal of general practice 50 (6), 357-362, 2021 | 38 | 2021 |
| Assessment of medical cannabis and health-related quality of life TR Arkell, LA Downey, AC Hayley, S Roth JAMA network open 6 (5), e2312522-e2312522, 2023 | 37 | 2023 |
| Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials TR Arkell, RC Kevin, F Vinckenbosch, N Lintzeris, E Theunissen, ... Addiction biology 27 (2), e13125, 2022 | 32 | 2022 |
| The effect of cannabidiol on simulated car driving performance: A randomised, double‐blind, placebo‐controlled, crossover, dose‐ranging clinical trial protocol D McCartney, MJ Benson, AS Suraev, C Irwin, TR Arkell, RR Grunstein, ... Human Psychopharmacology: Clinical and Experimental 35 (5), e2749, 2020 | 19 | 2020 |
| Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis NRPW Hutten, TR Arkell, F Vinckenbosch, J Schepers, RC Kevin, ... Psychopharmacology 239 (11), 3731-3741, 2022 | 18 | 2022 |
| A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance B Manning, TR Arkell, AC Hayley, LA Downey Journal of Psychopharmacology 38 (3), 247-257, 2024 | 12 | 2024 |
| Acute effects of amphetamine and related psychostimulants on impulsivity: a systematic review of clinical trials TR Arkell, K Bradshaw, LA Downey, AC Hayley Addiction biology 27 (2), e13128, 2022 | 11 | 2022 |
| Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey TR Arkell, SV Abelev, L Mills, A Suraev, JC Arnold, N Lintzeris, ... Journal of cannabis research 5 (1), 35, 2023 | 9 | 2023 |
| A semi-naturalistic, open-label trial examining the effect of prescribed medical cannabis on neurocognitive performance TR Arkell, B Manning, LA Downey, AC Hayley CNS drugs 37 (11), 981-992, 2023 | 8 | 2023 |
| Managing the high: developing legislation and detection methods for cannabis impairment TR Arkell, AC Hayley, LA Downey Nature Reviews Neuroscience 22 (9), 584-584, 2021 | 8 | 2021 |
| Randomised controlled trial (RCT) of daily aerobic exercise for inpatient cannabis withdrawal: A study protocol DJ Allsop, K Rooney, JC Arnold, AK Bhardwaj, R Bruno, DJ Bartlett, ... Mental Health and Physical Activity 13, 57-67, 2017 | 8 | 2017 |
| High standards: considerations for the application of the standard THC unit TR Arkell, AC Hayley, LA Downey The Lancet Psychiatry 8 (11), 947-948, 2021 | 7 | 2021 |
